Published in J Clin Endocrinol Metab on June 01, 1983
The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc (1994) 2.23
Does radiotherapy have a role in the management of thyroid orbitopathy? View 1. Br J Ophthalmol (2002) 2.04
The ophthalmopathy of Graves' disease. West J Med (1985) 1.39
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J (2016) 1.11
Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. BMJ (1988) 1.08
[Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy]. Ophthalmologe (2003) 1.02
High resolution magnetic resonance imaging of the anterior visual pathway in patients with optic neuropathies using fast spin echo and phased array local coils. J Neurol Neurosurg Psychiatry (1995) 0.95
The evaluation and treatment of graves ophthalmopathy. Med Clin North Am (2012) 0.91
Graves' orbitopathy: imperfect treatments for a rare disease. Eur Thyroid J (2013) 0.90
Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy. Korean J Ophthalmol (2012) 0.90
Ocular manifestations of Graves' disease: a review. J R Soc Med (1984) 0.88
Thyroid eye disease. Br J Ophthalmol (1996) 0.87
Medical management of thyroid eye disease. Saudi J Ophthalmol (2010) 0.87
Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial. Trials (2008) 0.87
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy. Graefes Arch Clin Exp Ophthalmol (2009) 0.80
Outcome of thyroid associated ophthalmopathy treated by radiation therapy. Radiat Oncol (2011) 0.78
Combined irradiation and low-dose cyclophosphamide in the treatment of Graves' ophthalmopathy. Postgrad Med J (1987) 0.78
Thyroid eye disease: towards an evidence base for treatment in the 21st century. Curr Neurol Neurosci Rep (2012) 0.78
Clinical outcomes of radiotherapy as initial local therapy for Graves' ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery. Radiat Oncol (2012) 0.77
[Octreotide scintigraphy for the diagnosis of active Graves' ophthalmopathy]. Ophthalmologe (2003) 0.75
Shopping for doctors: Thyroid eye disease patients are never satisfied. Oman J Ophthalmol (2011) 0.75
Radiotherapy in the treatment of Graves ophthalmopathy-to do it or not? J Ocul Biol Dis Infor (2009) 0.75
[Drug therapy and radiotherapy in Graves' orbitopathy]. Ophthalmologe (2011) 0.75
Natural history of graves' orbitopathy after treatment. Endocrine (2016) 0.75
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med (1998) 3.98
Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet (1983) 3.85
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet (1998) 2.62
Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab (2007) 2.45
Thyroid cancer after Chernobyl. Nature (1992) 2.35
Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab (1997) 2.11
Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol (1998) 2.09
Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev (2000) 2.06
Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab (1994) 2.05
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab (2005) 1.98
Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab (2004) 1.94
Video-assisted versus conventional parathyroidectomy in primary hyperparathyroidism: a prospective randomized study. Surgery (1999) 1.92
Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest (2005) 1.86
Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med (1989) 1.80
Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer (2011) 1.78
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. J Clin Endocrinol Metab (2012) 1.78
Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med (1996) 1.77
Minimally invasive surgery for thyroid small nodules: preliminary report. J Endocrinol Invest (1999) 1.77
Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab (2003) 1.75
The effects of amiodarone on the thyroid. Endocr Rev (2001) 1.75
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid (2001) 1.73
Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet (1992) 1.68
Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. J Clin Endocrinol Metab (1995) 1.62
Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol (2006) 1.59
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano) (2000) 1.59
Mutations in the gene encoding thyroid transcription factor-1 (TTF-1) are not a frequent cause of congenital hypothyroidism (CH) with thyroid dysgenesis. Thyroid (1997) 1.56
The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab (1999) 1.56
In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest (2003) 1.54
The aging thyroid. Endocr Rev (1995) 1.53
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC). Clin Endocrinol (Oxf) (2011) 1.52
Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. Thyroid (2000) 1.52
Follow-up study of patients with respiratory disease due to toluene diisocyanate (TDI). Clin Allergy (1984) 1.50
Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. Clin Endocrinol (Oxf) (1994) 1.50
Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology. J Clin Endocrinol Metab (2010) 1.50
Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer (2009) 1.49
Autonomous thyroid nodule and percutaneous ethanol injection. Lancet (1991) 1.48
Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab (1994) 1.48
High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy. Acta Endocrinol (Copenh) (1992) 1.47
Neuropsychological assessment in schoolchildren from an area of moderate iodine deficiency. J Endocrinol Invest (1990) 1.46
Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. Thyroid (2001) 1.45
Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab (1991) 1.45
Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens. Am J Clin Pathol (1991) 1.45
Thyroid and lipid metabolism. Int J Obes Relat Metab Disord (2000) 1.42
Percutaneous ethanol injection treatment of autonomous thyroid adenoma: hormonal and clinical evaluation. Clin Endocrinol (Oxf) (1992) 1.41
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding. Int J Obes (Lond) (2011) 1.41
Failure to detect thyroid growth-promoting activity in immunoglobulin G of patients with endemic goiter. J Clin Endocrinol Metab (1994) 1.40
D-lysine reduces the non-enzymatic glycation of proteins in experimental diabetes mellitus in rats. Diabetologia (1993) 1.40
Insulin autoantibodies as markers of potential diabetes mellitus. Lancet (1989) 1.40
Study of serum 3,5,3'-triiodothyronine sulfate concentration in patients with systemic non-thyroidal illness. Eur J Endocrinol (1996) 1.38
The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia (1989) 1.38
Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications. Horm Metab Res (1974) 1.36
Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab (1990) 1.36
Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab (1979) 1.36
Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab (1996) 1.35
Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res (1995) 1.33
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33
Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest (1986) 1.31
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab (2001) 1.31
Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) (2007) 1.30
Endoscopic parathyroidectomy: report of an initial experience. Surgery (1998) 1.28
Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med (1998) 1.28
Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab (1997) 1.25
Lectin-induced expression of DR antigen on human cultured follicular thyroid cells. Nature (1983) 1.25
Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab (2002) 1.25
Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dsfunction in apparently healthy subjects. J Endocrinol Invest (2001) 1.23
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab (2001) 1.23
Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrinol Metab (1993) 1.23
Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. J Clin Endocrinol Metab (1992) 1.22
Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. Lancet (1998) 1.20
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol (2006) 1.19
Risk of thyroid nodules in subjects occupationally exposed to radiation: a cross sectional study. Occup Environ Med (1995) 1.18
Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery (1996) 1.17